C
badmedisin said:I've been told diabetics should never take ibuprofen. I've also been told it's fine. Hmm.
What worries me is that they never warn you about the very serious risk of it causing stomach ulcers. Not the normal kind of ulcers that can be cured by antibiotics, rather the kind that basically destroy your stomach lining and leave you in debilitating pain for the rest if your life. If you really must take ibuprofen, ALWAYS eat just before you take it. If it's mixed up with food in your stomach it is less likely to stick to your stomach lining and cause permanent damage. I think this goes for alltablets to some extent, unless you are specifically told to take it on an empty stomach. It's just one of those things doctors never tell you when they prescribe things, like how you should always eat if you have to take emergency contraception otherwise you will puke and have to go back for more. I just wish they would tell you rather than waiting for you to work it out on your own!
Alternatives to Ibuprofen from the BNF59 prescribing information.
Ibuprofen is a propionic acid derivative with anti-inflammatory, analgesic, and antipyretic properties. It has fewer side-effects than other non-selective NSAIDs but its anti-inflammatory properties are weaker. Doses of 1.6 to 2.4 g daily are needed for rheumatoid arthritis and it is unsuitable for conditions where inflammation is prominent, such as acute gout. Dexibuprofen is the active enantiomer of ibuprofen. It has similar properties to ibuprofen and is licensed for the relief of mild to moderate pain and inflammation.
Other propionic acid derivatives:
Naproxen is one of the first choices because it combines good efficacy with a low incidence of side-effects (but more than ibuprofen, see CSM comment below).
Fenbufen is claimed to be associated with less gastro-intestinal bleeding, but there is a high risk of rash (see under Fenbufen).
Fenoprofen is as effective as naproxen, and flurbiprofen may be slightly more effective. Both are associated with slightly more gastro-intestinal side-effects than ibuprofen.
Ketoprofen has anti-inflammatory properties similar to ibuprofen and has more side-effects (see also CSM advice below). Dexketoprofen, an isomer of ketoprofen, has been introduced for the short-term relief of mild to moderate pain.
Tiaprofenic acid is as effective as naproxen; it has more side-effects than ibuprofen (important: reports of severe cystitis, see CSM advice under Tiaprofenic acid).
Drugs with properties similar to those of propionic acid derivatives:
Azapropazone is similar in effect to naproxen; it has a tendency to cause rashes and is associated with an increased risk of severe gastro-intestinal toxicity (important: see CSM restrictions).
Diclofenac and aceclofenac have actions and side-effects similar to those of naproxen.
Etodolac is comparable in efficacy to naproxen; it is licensed for symptomatic relief of osteoarthritis and rheumatoid arthritis.
Indometacin (indomethacin) has an action equal to or superior to that of naproxen, but with a high incidence of side-effects including headache, dizziness, and gastro-intestinal disturbances (see also CSM advice below).
Mefenamic acid has minor anti-inflammatory properties. It has occasionally been associated with diarrhoea and haemolytic anaemia which require discontinuation of treatment.
Meloxicam is licensed for the short-term relief of pain in osteoarthritis and for long-term treatment of rheumatoid arthritis and ankylosing spondylitis.
Nabumetone is comparable in effect to naproxen.
Phenylbutazone is licensed for ankylosing spondylitis, but is not recommended because it is associated with serious side-effects, in particular haematological reactions; it should be used only in severe cases by a specialist.
Piroxicam is as effective as naproxen and has a long duration of action which permits once-daily administration. However, it has more gastro-intestinal side-effects than most other NSAIDs, and is associated with more frequent serious skin reactions.
Sulindac is similar in tolerance to naproxen.
Tenoxicam is similar in activity and tolerance to naproxen. Its long duration of action allows once-daily administration.
Tolfenamic acid is licensed for the treatment of migraine.
Ketorolac and the selective inhibitor of cyclo-oxygenase-2, parecoxib, are licensed for the short-term management of postoperative pain.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?